In Philadelphia, breast cancer survivors paddle toward wellness together with dragon boat racing
"My life is better for it. It's an incredible community of people who have gone through some version of what I've been through," said Catherine Hagele, a breast cancer survivor and member of the Hope Afloat dragon boat racing team.
After finding a lump in 2017 when she was 49, Hagele had surgery, chemo and radiation.
"It was the hardest thing I've ever done," she said.
She said a big part of her recovery was finding this dragon boat racing team.
Paddling their way to wellness in unison, the team called Hope Afloat even created a special song for themselves.
Linda Giovinco lost her mother and sister to breast cancer, and then she was diagnosed. She said the team saved her life.
"It's increased my confidence, it's given me a sense of camaraderie," Giovinco said. "Having lost a sister, I got all these sisters."
Hagele, who works at Penn Medicine, recently received a Penn CAREs grant to supply equipment and discounted memberships for the team.
The team ranges in age from 30 to 85 and welcomes all breast cancer patients and survivors, no matter their ability.
And a few have been selected to be part of Team USA at the World Dragon Boat Racing Championships in Germany in July.
"They are having an inaugural breast cancer survivor division, and so I'm part of the first team," Hagele said.
Beyond the support and friendships, research shows dragon boat racing can help reduce breast cancer complications.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets
GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of Ozempic (semaglutide) and Wegovy (semaglutide) pens are available to eligible self-paying patients for $499-per-month through GoodRx, effective immediately. GoodRx offers a platform for medication savings in the U.S. The collaboration significantly lowers the price available on GoodRx for two of the most in-demand GLP-1 medications nationwide, expanding access for those without adequate insurance move also marks the first time Ozempic has been made available to patients at this self-pay price. In the last year, almost 17 million people came to GoodRx looking for savings and information on GLP-1 medications, a 22% increase from the previous year. Now, GoodRx is poised to meet this growing demand more effectively. GoodRx research shows 19 million people lack coverage for any GLP-1s prescribed for weight loss. By filling the gaps in insurance coverage, GoodRx is playing a critical role in reducing friction in the system and helping accelerate speed to therapy so consumers can benefit from these critical treatments. Starting today, eligible patients can use GoodRx to self-pay for Ozempic and Wegovy pens for $499-per-month at over 70,000 retail pharmacies nationwide. In March, Novo Nordisk introduced NovoCare Pharmacy, a direct-to-patient delivery service to improve access to Wegovy for cash-paying patients. The program offers all dosage strengths of the weight-loss medication at a reduced price of $499 per month for uninsured individuals or those whose insurance does not cover obesity treatments. In June, Eli Lilly and Co. (NYSE:LLY) announced that the highest approved doses of Zepbound (tirzepatide), 12.5 mg and 15 mg, would soon be available in single-dose vials for $499 per month through LillyDirect's Self Pay Pharmacy Solutions and the Zepbound Self Pay Journey Program. Healthcare providers began prescribing the 12.5 mg and 15 mg vials on July 7; shipments to patients began in early August. With the addition of these doses, every strength of Zepbound vial will be available for $499/month or less ($349 for the 2.5 mg starter dose) to any eligible adult with obesity and a valid prescription, regardless of insurance. After the update, Hims & Hers Health Inc (NYSE:HIMS) stock is trading 2.35% lower at $44.94. In June, Novo Nordisk terminated its collaboration with Hims & Hers Health. On Saturday, the U.S. Food and Drug Administration (FDA) approved an additional indication for Wegovy (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical activity. Price Action: GDRX stock is trading higher by 30.83% to $4.880 at last check Monday. Read Next:Photo by KK Stock via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
17 minutes ago
- Bloomberg
Texas Declares Measles Outbreak Over With No Cases Since July
The Texas Department of State Health Services reported the end of the state's measles outbreak on Monday, after a surge of infections this year drove the US to the worst outbreak in three decades. The health department said no new cases in areas with previous high transmission had been reported for 42 days, the length of time necessary for public health leaders to declare an end to an outbreak. Since January, the state has recorded 762 total cases. Two unvaccinated children died from measles-related complications.
The Verge
17 minutes ago
- The Verge
The Apple Watch Ultra is on sale for a record low of $650
If you're interested in a long-lasting smartwatch, and like to stay within Apple's hardware ecosystem, the Apple Watch Ultra 2 is the best choice. It's Apple's most durable, longest-lasting smartwatch, and it's currently on sale for $649.99 ($150 off), an all-time low price at Amazon and Best Buy. The Apple Watch Ultra 2 comes in a single case size (49mm), material (titanium), and configuration (GPS + Cellular), so the only choice you have to make is which band best fits your style. The rugged Apple Watch Ultra 2 comes in one size: 49mm. It offers the brightest display of any wearable in Apple's lineup, along with better battery life and improved performance. It sports Apple's new S9 SiP, too, allowing you to take advantage of Apple's new double tap feature. Read our review. The Apple Watch Ultra 2's battery lasted roughly two and a half days in our tests, and Apple says you can get up to 72 hours with low power mode enabled. If you have the right accessories, you can charge the Apple Watch Ultra 2 from zero to 80 percent in under an hour. The smartwatch's S9 SiP processor is powerful enough to handle on-device Siri queries, and enables the double tap gesture, which allows you to scroll or interact with buttons on its display by tapping your fingers instead of the screen. Apple introduced the S10 SiP with the Apple Watch Series 10 last year, but the Apple Watch Ultra 2's processor is still plenty powerful. The Apple Watch Ultra 2 supports several health and wellness features, including sleep apnea detection, fall detection, crash detection, sleep tracking, and heart tracking. The watch will send you a notification if it detects atrial fibrillation, and allows you to take an EKG (electrocardiogram) on device. Apple recently re-enabled the Apple Watch's ability to monitor your blood oxygen level, though you'll need to review the readings within your iPhone's health app. When you exercise, you can select from a list of dozens of workout types to accurately log your fitness routine. Apple has traditionally announced Apple Watch hardware updates at its iPhone event typically held in September, and rumors suggest the Apple Watch Ultra 3 will have a larger display, but the Ultra 2 is an excellent choice at its sale price. Sign up for Verge Deals to get deals on products we've tested sent to your inbox weekly. Posts from this author will be added to your daily email digest and your homepage feed. See All by Brandt Ranj Posts from this topic will be added to your daily email digest and your homepage feed. See All Apple Posts from this topic will be added to your daily email digest and your homepage feed. See All Deals Posts from this topic will be added to your daily email digest and your homepage feed. See All Gadgets Posts from this topic will be added to your daily email digest and your homepage feed. See All Smart Home Posts from this topic will be added to your daily email digest and your homepage feed. See All Smartwatch Posts from this topic will be added to your daily email digest and your homepage feed. See All Speakers Posts from this topic will be added to your daily email digest and your homepage feed. See All Tech Posts from this topic will be added to your daily email digest and your homepage feed. See All Wearable
